Bottom line
Is VPMCX a good fund? The bottom line
VPMCX is the Investor share class of Vanguard PRIMECAP Fund, a managed large blend mutual fund from Vanguard.
It charges 0.35% — about $35 a year on every $10,000 invested, cheaper than 86% of large blend funds we track.
It returned +29.9% over one year, +14.3% a year over five years, +15.2% a year over ten (as of Dec 31, 2025, per its prospectus).
With $96.1 billion in net assets and 173 holdings, its largest position is Micron Technology Inc (13.5%) and the top 10 make up 44.9% of the portfolio.
What stands out
- Low cost: cheaper than 86% of large blend peers
- 5-year return beat 86% of category peers
- No front-end sales load
- Large and established ($96.1 billion)
Updated Nov 19, 2026
What VPMCX invests in
Vanguard PRIMECAP Fund (the Fund) seeks to provide long-term capital appreciation.
The Fund employs an active management approach, investing in stocks considered to have above-average earnings growth potential that is not reflected in their current market prices. The Funds portfolio consists predominantly of large- and mid-capitalization stocks. The Fund may invest up to 25% of its assets in foreign securities, which may include depositary receipts. Foreign securities may be traded on U.S. or foreign markets.
From the fund's prospectus (filed Jan 28, 2026).
VPMCX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| VPMCX | +29.9% | +14.3% | +15.2% |
| Large Blend median | +13.8% | +9.7% | +10.9% |
Source: Fund prospectus, as of Dec 31, 2025
What VPMCX costs
On a $10,000 investment, VPMCX's 0.35% expense ratio costs about $35 a year. The prospectus estimates $443 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.
VPMCX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Micron Technology Inc | 13.50% |
| 2 | Intel Corp | 6.80% |
| 3 | Eli Lilly & Co | 6.76% |
| 4 | KLA Corp | 3.85% |
| 5 | Alphabet Inc | 3.52% |
| 6 | AstraZeneca PLC | 2.35% |
| 7 | NVIDIA Corp | 2.33% |
| 8 | Amazon.com Inc | 2.05% |
| 9 | Tesla Inc | 1.89% |
| 10 | Biogen Inc | 1.88% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 44.9% of the fund. See all top 25 holdings and asset mix →